E-LIB Suche - Ergebnisse für: Dubischar, Katrin

1

Combined immunogenicity evaluation for a new single-dose li..:

Buerger, Vera ; Maurer, Gabriele ; Kosulin, Karin...
Journal of Travel Medicine. , 2024

Link: https://doi.org/10.1093/..

2

Optimisation of dose level and vaccination schedule for the..:

Bézay, Nicole ; Wagner, Laura ; Kadlecek, Vera...
The Lancet Infectious Diseases. , 2024

Link: https://doi.org/10.1016/..

3

Immunogenicity and safety of an 18-month booster dose of th..:

Ghadge, Santhosh Kumar ; Schneider, Martina ; Dubischar, Katrin...
The Lancet Infectious Diseases. , 2024

Link: https://doi.org/10.1016/..

4

Safety and immunogenicity against ancestral, Delta and Omic..:

Taucher, Christian ; Lazarus, Rajeka ; Dellago, Hanna...
Journal of Infection. 87 (2023) 3 - p. 242-254 , 2023

Link: https://doi.org/10.1016/..

5

Safety and immunogenicity of a single-shot live-attenuated ..:

Schneider, Martina ; Narciso-Abraham, Marivic ; Hadl, Sandra...
The Lancet. 401 (2023) 10394 - p. 2138-2147 , 2023

Link: https://doi.org/10.1016/..

6

A randomized, double-blinded Phase 3 study to demonstrate l..:

McMahon, Robert ; Fuchs, Ulrike ; Schneider, Martina...
Journal of Travel Medicine. 31 (2023) 2 - p. , 2023

Link: https://doi.org/10.1093/..

7

Immunogenicity and safety of an inactivated whole-virus COV..:

Lazarus, Rajeka ; Querton, Benedicte ; Corbic Ramljak, Irena...
The Lancet Infectious Diseases. 22 (2022) 12 - p. 1716-1727 , 2022

Link: https://doi.org/10.1016/..

8

Safety and immunogenicity of the inactivated whole-virus ad..:

Lazarus, Rajeka ; Taucher, Christian ; Brown, Claire...
Journal of Infection. 85 (2022) 3 - p. 306-317 , 2022

Link: https://doi.org/10.1016/..

9

A randomized, placebo-controlled, blinded phase 1 study inv..:

Wressnigg, Nina V ; Hochreiter, Romana ; Schneider, Martina...
Journal of Travel Medicine. , 2022

Link: https://doi.org/10.1093/..

10

Neutralizing antibody persistence in pediatric travelers fr..:

Taucher, Christian ; Barnett, Elizabeth D. ; Cramer, Jakob P....
Travel Medicine and Infectious Disease. 34 (2020) - p. 101616 , 2020

Link: https://doi.org/10.1016/..

11

Efficacy, immunogenicity, and safety of IC43 recombinant Ps..:

Adlbrecht, Christopher ; Wurm, Raphael ; Depuydt, Pieter...
Critical Care. 24 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

12

Persistence of the immune response after vaccination with t..:

Taucher, Christian ; Kollaritsch, Herwig ; Dubischar, Katrin L.
Vaccine. 37 (2019) 19 - p. 2529-2531 , 2019

Link: https://doi.org/10.1016/..

13

Safety and immunogenicity of an inactivated Vero cell_deriv..:

Jelinek, Tomas ; Cromer, Michael A. ; Cramer, Jakob P....
Travel Medicine and Infectious Disease. 22 (2018) - p. 18-24 , 2018

Link: https://doi.org/10.1016/..

14

Safety, immunogenicity and dose response of VLA84, a new va..:

Bézay, Nicole ; Ayad, Andrea ; Dubischar, Katrin...
Vaccine. 34 (2016) 23 - p. 2585-2592 , 2016

Link: https://doi.org/10.1016/..

15

Immunogenicity and safety of the inactivated Japanese encep..:

Cramer, Jakob P. ; Dubischar, Katrin ; Eder, Susanne...
Vaccine. 34 (2016) 38 - p. 4579-4585 , 2016

Link: https://doi.org/10.1016/..